2026-06-29 — UK gene-editing company Tropic Biosciences raised a $105M Series C co-led by Forbion Capital Partners and Corteva Catalyst to advance gene-edited…
Tropic Biosciences, a UK-based developer of gene-edited crops, has raised $105 million in a Series C round. The financing was co-led by Forbion Capital Partners and Corteva Catalyst.
The round was one of the larger agtech financings reported in early 2026, a period in which investors concentrated capital in later-stage companies with demonstrated traction.
Corteva Catalyst, the strategic investment arm of Corteva, has been among the most visible corporate backers in agtech this year, appearing as a lead investor across multiple biologicals and crop-genetics rounds.
Tropic Biosciences raises $105M Series C for gene-edited crops
UK gene-editing company Tropic Biosciences raised a $105M Series C co-led by Forbion Capital Partners and Corteva Catalyst to advance gene-edited crops.
Tropic Biosciences, a UK-based developer of gene-edited crops, has raised $105 million in a Series C round. The financing was co-led by Forbion Capital Partners and Corteva Catalyst.
The round was one of the larger agtech financings reported in early 2026, a period in which investors concentrated capital in later-stage companies with demonstrated traction.
Corteva Catalyst, the strategic investment arm of Corteva, has been among the most visible corporate backers in agtech this year, appearing as a lead investor across multiple biologicals and crop-genetics rounds.
